Acadia Healthcare Company (ACHC) Stephens 26th Annual Investment Conference | NASH2024 summary
Event summary combining transcript, slides, and related documents.
Stephens 26th Annual Investment Conference | NASH2024 summary
13 Jan, 2026Market and policy environment
Bipartisan support for mental health continues, with strong demand for services and favorable reimbursement trends expected to persist into 2025.
Medicaid supplemental payment programs are seen as stable and likely to continue regardless of political shifts, with recent years showing increased inclusion of behavioral health facilities.
Policy changes are not expected to materially impact behavioral health coverage, and industry funding momentum is bipartisan and state-driven.
Business performance and volume trends
Same facility patient day growth was 4.7% in Q3 and over 5% in September, but moderated to around 3% in October due to local media coverage following a government investigation.
The moderation in volume is considered transitory, with proactive outreach and communication efforts underway to stabilize referral relationships.
Localized media impacts have affected both acute and specialty business lines, with referral volumes and consumer-driven admissions both seeing some pressure.
Referral sources and joint ventures
Increased engagement with referral sources, including in-person meetings and educational luncheons, has led to improvements in referral patterns.
Joint venture partners remain supportive, with new facilities opening soon and a robust pipeline of additional JV and De Novo projects.
Existing JV partners serve as strong references, aiding in the development of new partnerships even amid heightened media scrutiny.
Latest events from Acadia Healthcare Company
- 2026 guidance targets $3.37B–$3.45B revenue, with growth driven by new bed ramp-up and cost discipline.ACHC
47th Annual Raymond James Institutional Investor Conference26 Mar 2026 - Proxy covers director elections, incentive plan amendment, say-on-pay, and auditor ratification.ACHC
Proxy filing25 Mar 2026 - Annual meeting to vote on directors, compensation, and auditor ratification; board recommends approval.ACHC
Proxy filing25 Mar 2026 - Operational focus shifts to filling new beds, managing policy headwinds, and reducing debt.ACHC
Barclays 28th Annual Global Healthcare Conference10 Mar 2026 - Organizational changes and cost controls aim to boost growth as CapEx drops and debt reduction takes priority.ACHC
Leerink Global Healthcare Conference 20269 Mar 2026 - 2026 guidance targets revenue growth, lower CapEx, and operational focus amid regulatory headwinds.ACHC
Q4 202525 Feb 2026 - Q2 revenue up 8.8% to $796M, net income $78.5M, and growth continues despite facility closures.ACHC
Q2 20242 Feb 2026 - Q3 revenue up 8.7% to $815.6M; 2024 guidance revised after facility closures and media scrutiny.ACHC
Q3 202417 Jan 2026 - Bed expansion, operational gains, and technology investments drive future growth.ACHC
44th Annual J.P. Morgan Healthcare Conference14 Jan 2026